1. Hauptnavigation
  2. Navigation des Hauptbereiches
  3. Inhalt der Seite

Press Officer and Head of Press and Public Relations

Dr. Stefanie Seltmann
Dr. Stefanie Seltmann

Im Neuenheimer Feld 280
69120 Heidelberg

Phone: +49 6221 422854
Fax: +49 6221 422968

E-Mail: s.seltmann@dkfz.de
or presse@dkfz.de

Recent Press Releases

No. 36 | 21. July 2014 | by Sel

Using light to control the cell

Using light to control the cell

Researchers from the University of Heidelberg and the German Cancer Research Center (DKFZ) have developed a new method that uses light to control processes in living cells. This system facilitates studies on the movement of proteins within cells and is of interest for both basic and applied research. The scientists have now published their results in the journal “Nature Communications.”
Joint press release of the German Cancer Research Center (DKFZ) and the University of Heidelberg

No. 34 | 10. July 2014 | by Koh

Federal Health Minister Hermann Gröhe visits the German Cancer Research Center and the National Center for Tumor Diseases

Federal Health Minister Hermann Gröhe visits the German Cancer Research Center and the National Center for Tumor Diseases

This year, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) celebrates its 50th anniversary, and the National Center for Tumor Diseases (NCT) Heidelberg celebrates its 10th anniversary. On the occasion of this joint anniversary, Federal Minister of Health Hermann Gröhe made a visit to both institutes in Heidelberg.

No. 32 | 25. June 2014 | by Koh

First positive results toward a therapeutic vaccine against brain cancer

First positive results toward a therapeutic vaccine against brain cancer

Tumor vaccines might help the body fight cancer. A prerequisite to the development of such a vaccination is to find protein structures in cancer cells that differ from those of healthy cells. Such differences are often created by gene mutations in tumor cells, which lead to altered proteins that cells of the immune system can potentially recognize. Cancer researchers from Heidelberg have now been able to develop a mutation-specific vaccine targeting a protein that is mutated in brain cancer. In the journal “Nature”, the researchers report that the vaccine arrested tumor growth in mice.
Joint press release of the German Cancer Research Center and the Heidelberg University Hospital

Audio (in German only)
einblick (in German only)
Publications
Videos (in German only)
last update: 16/10/2013 back to top